A Q&A with ‘Rising Leader’ Therese Liechtenstein
Therese was selected as one of the top 30 Rising Leaders in the 3rd annual listing of In Vivo’s ‘Rising Leaders’ 2022.
Therese was selected as one of the top 30 Rising Leaders in the 3rd annual listing of In Vivo’s ‘Rising Leaders’ 2022.
Do you want to help advise some of the world’s leading healthcare and life sciences companies that are developing novel medicines and treatments to improve the quality of life for millions of people?
As part of a panel session, hosted by Stephen Hansen, at the Anglonordic Life Science conference on 5 May, Optimum’s clients explored the latest dynamics of syndicate building for early-stage VCs.
Stephanie Bewick, Chief Business Officer at Destiny Pharma outlines her experiences of how a CBO maximises their company’s commercial appeal and lands deals in the biotech industry…
The 3rd annual listing of In Vivo’s ‘Rising Leaders’ has landed! Optimum … Continue reading “In Vivo’s 30 ‘Rising Leaders’ Announced”
Optimum is a proud supporter of LSX. Every year it’s World Congress gathers the founders and CEOs of innovative start-ups through to publicly healthcare giants, and everyone in between.
AMSilk is the world’s first industrial supplier of vegan silk biopolymers that are biodegradable, recyclable, renewable and zero-waste.
As one of the organisers, Optimum is proud to partner with Anglonordic year on year to curate an awesome agenda for this fantastic event. Exclusively for European investors and R&D companies…
Destiny Pharma CEO, Neil Clark interviewed by Amy Brown at Evaluate Vantage
Article by Dr Roger Dmochowski, Professor of Urology & Advisory Board Member of Versameb
In the spirit of spreading the message on sustainability, especially throughout the healthcare industry, Optimum decided to celebrate International Women’s Day 2022 by asking the brilliant women in healthcare what the subject of ESG means to them.
As part of its ‘Pharma Outlook for 2022’, leading healthcare publication, In … Continue reading “What Next After A Year Of Innovation And Growth?”
We are proud to work with amazing companies focused on developing new treatments for rare diseases, generating change for the 300 million people worldwide
In January, AMSilk, a world leader in supplying innovative high-performance bio-based silk … Continue reading “AMSilk’s certified-vegan, silk-like BioSteel fibre, is used by Mercedes-Benz for its VISION EQXX.”
2021 was an outstanding year for Novo Seeds in terms of venture … Continue reading “Novo Seeds – Building Exceptional Companies for Global Impact”
As a supporter of Sachs Associates, Optimum is pleased to be able to offer a 10% discount on its brilliant events coming up in 2022.
The Optimum Team are looking forward to the Scrip Awards on Thursday 2nd December, always a … Continue reading “Scrip Award Nominees 2021”
Watch a replay of the live session here or read our top takeaways below…
Watch a replay of the live session here or read our top takeaways below…
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...
GET IN TOUCH
© Copyright 2022 Optimum Strategic Communications All rights reserved.
The Spice Building
8 Devonshire Square
London
EC2M 4PL
Tel: +44 (0)203 950 9144
Email: contact@optimumcomms.com
